폴리피드 (PYPD) 주가

폴리피드(PYPD)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $5.21 (+3.58%), 시가총액 $92.99M.

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors.

핵심 지표

• 현재가: $5.21 (+3.58%)
• 시가총액: $92.99M
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NAS

폴리피드의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

폴리피드 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 매수 (4.3 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 10.59
• 순이익률: 0.00%
• 영업이익률: 0.00%

자주 묻는 질문